8Deep Learning in Oncology: Applications in Diagnosis, Prognosis, and Personalized Treatment

Authors

  • Dr. Rahul Srivastava Professor Department of Pharmaceutics, Institute of Pharmaceutical Sciences, Lucknow, India Author
  • Dr. Komal Desai Professor Department of Pharmacology, Institute of Pharmaceutical Sciences, Lucknow, India Author
  • Mr. Ajay Kuldeep Associate Professor Department of Pharmaceutical Analysis, Institute of Pharmaceutical Sciences, Lucknow, India Author
  • Dr. Divya Menon Assistant Professor Department of Pharmacy Practice, Institute of Pharmaceutical Sciences, Lucknow, India Author
  • Mrs. Bhavana Rao Professor Department of Pharmacognosy, Institute of Pharmaceutical Sciences, Lucknow, India Author

Keywords:

Deep learning, Oncology, Artificial intelligence, Precision medicine, Digital pathology, Medical imaging, Radiomics, Cancer diagnosis, Personalized treatment, Prognosis.

Abstract

Background: Cancer remains one of the leading causes of morbidity and mortality worldwide, accounting for millions of new diagnoses and deaths each year. The remarkable biological heterogeneity of malignant tumors presents substantial challenges for accurate diagnosis, prognosis, therapeutic decision-making, and long-term disease monitoring. Conventional oncology relies on histopathology, radiological imaging, molecular diagnostics, and clinical evaluation; however, the growing complexity and volume of cancer-related data often exceed the capabilities of traditional analytical methods. Deep learning, a rapidly evolving branch of artificial intelligence, has emerged as a transformative technology capable of extracting high-dimensional patterns from complex biomedical datasets with minimal manual feature engineering. Convolutional neural networks, recurrent neural networks, graph neural networks, vision transformers, and hybrid deep learning architectures have demonstrated outstanding performance across multiple oncology applications, including tumor detection, image segmentation, cancer classification, survival prediction, genomic analysis, treatment response assessment, drug discovery, and precision medicine. These models enable integration of multimodal information derived from digital pathology, radiological imaging, genomic sequencing, transcriptomics, proteomics, and electronic health records to facilitate personalized therapeutic strategies. Despite their promising clinical utility, challenges related to interpretability, data heterogeneity, algorithmic bias, computational requirements, and regulatory approval continue to impede widespread clinical implementation. This review comprehensively discusses the principles, architectures, clinical applications, advantages, limitations, and future directions of deep learning in oncology, emphasizing its growing role in advancing precision cancer care and improving patient outcomes through intelligent data-driven decision support.

Downloads

Published

2026-06-20

How to Cite

Dr. Rahul Srivastava, Dr. Komal Desai, Mr. Ajay Kuldeep, Dr. Divya Menon, & Mrs. Bhavana Rao. (2026). 8Deep Learning in Oncology: Applications in Diagnosis, Prognosis, and Personalized Treatment. International Journal of Multidisciplinary Research in Biotechnology, Pharmacy, Dental and Medical Sciences , 2(6), 39-47. https://ijmrbpdms.org/index.php/files/article/view/66